Strategies for Enhancing Eyesight A Collaborative Educational Program to Improve Vision in Patients With Diabetes

1 AMA PRA Category 1 Credit(s) 1.2 KBN
Launch Date:
April 30, 2015
Expiration Date:
The accreditation for this activity has expired.

Primary Audience:

Primary Care Physicians, Endocrinologists, Certified Diabetes Educators

Relevant Terms:

Diabetic Macular Edema (DME), Diabetic Retinopathy (DR), Diabetic Eye Disease

David M. Brown, MD

David M. Brown, MD
Retina Specialist
Retina Consultants of Houston
Clinical Professor
Cullen Eye Institute
Department of Ophthalmology
Baylor College of Medicine
Houston, Texas

Dr. David M. Brown graduated from Baylor College of Medicine, Houston, Texas, and completed an ophthalmology residency and medical retina and vitreoretinal surgery fellowship at The University of Iowa, Iowa City, Iowa. In 1993, he was awarded the Ronald G. Michels Fellowship Award as the most outstanding retina fellow in the United States. Dr. Brown’s research and clinical interests are focused on diseases of the macula: macular surgery, age-related macular degeneration (AMD), and diabetic retinopathy. An elected member of The Macula Society and of The Retina Society, he directs one of the largest clinical trial centers for retinal disease in the United States. He has published and written more than 150 national meeting presentations, abstracts, and scientific papers, including many of the primary papers establishing the use of anti-VEGF agents for AMD, central retinal vein occlusion, and diabetic retinopathy. Dr. Brown serves as a peer reviewer for all five major ophthalmology/retina journals, and also for The New England Journal of Medicine. He is a former president of the Houston Ophthalmological Society and has served on the board of directors for the Greater Houston Area American Diabetes Association as well as for the Gulf Coast Juvenile Diabetes Research Foundation. He is an elected member of both major retina honor societies—The Macula Society and The Retina Society. From 2007 to 2011, Dr. Brown was selected by his peers, nationwide, as one of “America’s Best Doctors” and is a Texas Monthly “Super Doc.”

Michael J. Elman, MD

Michael J. Elman, MD
Retina Specialist
Elman Retina Group
Assistant Professor of Ophthalmology
Johns Hopkins University School of Medicine
Baltimore, Maryland

Dr. Elman has practiced ophthalmology for over 30 years, specializing in diseases of the retina and vitreous. Author of more than 150 publications on retinal diseases and surgery, Dr. Elman is an Assistant Professor of Ophthalmology at the Johns Hopkins University School of Medicine. He is currently the Director of Retina Surgery at Franklin Square Hospital. Dr. Elman directed the Clinical Research Unit at the University of Maryland and was bestowed the Young Scholar Award for the entire University of Maryland. Dr. Elman is one of only 280 ophthalmologists worldwide elected to the prestigious American Ophthalmological Society. He serves as the national Study Chairman of the Diabetic Retinopathy Clinical Research Network (DRCRnet) Protocol I, a national collaborative clinical trial that recently revolutionized the treatment of diabetic macular edema. Dr. Elman, a member of the DRCRnet's Executive Committee, served as its chairman last year.
Certified by the American Board of Ophthalmology and a fellow of the American Academy of Ophthalmology, Dr. Elman is a graduate of Wayne State School of Medicine. He completed his internship in internal medicine at Sinai Hospital of Detroit and his residency in ophthalmology at the University of Illinois Eye Center in Chicago. He received fellowship training in Retinal Vascular Diseases at the Wilmer Eye Institute of the Johns Hopkins University and fellowship training in Diseases and Surgery of the Retina and Vitreous at Barnes Hospital/Retina Consultants, Ltd. of Washington University. Dr. Elman and his wife are actively involved in many community and philanthropic organizations. Together, they are the devoted parents of four children and doting grandparents to six grandchildren.

Anne Peters, MD

Anne Peters, MD
Keck School of Medicine of University of Southern California (USC)
Director, USC Clinical Diabetes Programs
Los Angeles, California

Anne Peters, MD, is a professor at the Keck School of Medicine of the University of Southern California (USC) and the director of the USC Clinical Diabetes Programs. She runs diabetes centers in Beverly Hills, California, and in underserved East Los Angeles and works with the LA County Department of Health Services on a county-wide diabetes program. Dr Peters earned her undergraduate degree from Wesleyan University in Middletown, Connecticut, and her medical degree from the Pritzker School of Medicine at the University of Chicago, Chicago, Illinois. She performed her internal medicine residency at Stanford University, Stanford, California, and Harbor-University of California, Los Angeles (UCLA) Medical Center (final year) and a fellowship in endocrinology at Cedars-Sinai Medical Center in Los Angeles. She was in charge of the clinical diabetes programs at Cedars and then at UCLA before moving to USC. Dr Peters has been a principal investigator on multiple clinical trials focusing on diabetes and diabetes prevention. She established the Community Diabetes Initiatives Research Center in collaboration with Children’s Hospital Los Angeles with funding from the Keck Foundation, JDRF, American Diabetes Association (ADA), National Institutes of Health (NIH), Rose Hills Foundation, California Nutrition Network, TrialNet, and Helmsley Trust. Dr Peters is a principal investigator on 3 NIH grants: the NIH Look AHEAD (Action for Health in Diabetes) study, the UCLA/USC NIH P50 program project, “Family and Neighborhood Interventions to Reduce Heart Disease Risk in East L.A.”, and the NIH Vitamin D and Type 2 Diabetes (D2d) Study. She has been an invited speaker at hundreds of local, national, and international medical conferences. Dr Peters has authored 3 books on diabetes and more than 100 articles appearing in peer-reviewed medical journals, including JAMA,The New England Journal of Medicine, Annals of Internal Medicine, and Diabetes Care. She serves on the American Board of Internal Medicine Endocrine Board, multiple ADA committees, and the EASD (European Association for the Study of Diabetes)/ADA Diabetes Technology Committee. Dr Peters received the ADA Outstanding Physician Clinician Award in 2008 and the 2010 Bernardo Houssay Award from the National Minority Quality Forum for her work with the underserved. She is an author of the ADA/EASD Position Statement on the Management of Hyperglycemia in Type 2 Diabetes and the upcoming ADA Position Statement on the Treatment of Type 1 Diabetes Across the Lifespan.
1. Refer patients to an eye care specialist annually for early detection of DR and DME
2. Counsel patients regarding the importance of annual eye examinations in early detection of DR and DME for prevention of vision loss
3. Select glycemic control agents least likely to contribute to DME
4. Incorporate the results of eye examinations and DME treatment into patient counseling
5. Describe special considerations for care of underserved patient populations
6. Integrate effective communication and coordination of patient care with eye care specialists

Last Review Date: April 29, 2015
AMA Credit Designation Statement
The University of Louisville Continuing Medical Education & Professional Development designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Credit Designation Statement
This program has been approved by the Kentucky Board of Nursing for 1.2 continuing education credit through University of Louisville Hospital, provider number 4-0068-7-16-843. The Kentucky Board of Nursing approval of an individual nursing education provider does not constitute endorsement of program content.
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Louisville and MedEdicus LLC. The University of Louisville School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Instructions & Registration
This activity takes approximately 1 hour. After completing the activity you will have the option of taking the post test and evaluation online. You must answer 7 out of 10 questions correctly in order to pass, and may take the test up to 2 times. Upon registering and successfully completing the post test, your certificate will be made available online and you can print it or file it. Please make sure you take the online post test and evaluation on a device that has printing capabilities. There are no fees for participating in and receiving credit for this activity.

Course Viewing Requirements
Supported Browsers:
Internet Explorer 8.0+ for Windows 2000, 2003, Vista, XP, Windows 7, Windows 8
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6+ for Mac OSX 10.7 and above

For video playback, install the latest version of Flash or Quicktime.
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above


As a sponsor accredited by the ACCME, the University of Louisville School of Medicine must ensure balance, independence, objectivity, and scientific rigor in all its sponsored educational activities. All faculty participating in this CME activity were asked to disclose the following:

  1. Names of proprietary entities producing health care goods or services—with the exemption of nonprofit or government organizations and non–health-related companies—with which they or their spouse/partner have, or have had, a relevant financial relationship within the past 12 months. For this purpose, we consider the relevant financial relationships of a spouse/partner of which they are aware to be their financial relationships.
  2. Describe what they or their spouse/partner received (eg, salary, honorarium).
  3. Describe their role.
  4. No relevant financial relationships.
Commercial Entity
With Whom There Is
a Relevant Financial Relationship
(or None)
Nature of Relevant Financial Relationship
With Commercial Entity
(Speaker, Consultant, etc)
What was received?
For what role?
David M. Brown, MD, FACS (PC)
Alcon; Allergan; Bayer; Genentech; Novartis; Regeneron; ThromboGenics
Fee (All listed)
Aerpio; Alcon; Allergan; Ampio; Genentech; Novartis; Pfizer; Regeneron; ThromboGenics
Contracted Research
Michael J. Elman, MD (PC)
Genentech/Roche; OHR Pharmaceutical
Fee (All listed)
Speakers Bureau
Jaeb Center, OHR Pharmaceutical
Contracted Research
OHR Pharmaceutical
Stock Shareholder
Anne Peters, MD (PC)
Bristol-Myers Squibb; AstraZeneca; Novo Nordisk
Fee (All listed)
Speakers Bureau
Editorial Fees
Abbott Diabetes Care; Becton,
Dickinson; Bristol-Myers Squibb; AstraZeneca; Janssen; Lilly; Medtronic
Fee (All listed)
Medtronic MiniMed
Contracted Research
Diane McArdle, PhD (C)
John Sorenson, MD (PR)
Cynthia Tornallyay, RD, MBA, CCMEP (C)
Betty Villafuerte, MD (CD) (PR)
                        C=Cordinator; CD=Course Director; PC=Planning Committee; PR=Presentation Reviewer.
Medium or Combination of Media Used: Online Enduring Material Activity
Method of Physician Participation: Online/Digital Activity
Estimated Time to Complete the Educational Activity: 1.0 hour
CME & PD Staff and Advisory Board Disclosure
The CME & PD staff and Advisory Board have nothing to disclose with the exception of Dr. Douglas Coldwell: Sirtex, Inc. (Speaker) and DFine, Inc. (Consultant). 
Commercial Support
This activity is supported through an unrestricted educational grant from Genentech, Inc.
Special Services
If you need special accommodations because of a disability or for an alternative form of course materials, please contact us at Continuing Medical Education & Professional Development fully complies with the legal requirements of the ADA and the rules and regulations thereof.
Provider Contact Information
For questions about the CME activity content, please contact University of Louisville at
Privacy Policy
All information provided by course participants is confidential and will not be shared with any other parties for any reason without permission.
This continuing medical education activity is jointly provided by The University of Louisville Office of Continuing Medical Education and MedEdicus LLC.
This continuing medical education activity is supported through an unrestricted educational grant from Genentech, Inc.
Copyright ©2015 MedEdicus LLC